Monoprost (Latanoprost)

Latanoprost, the active ingredient in Monoprost, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It is employed to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension, helping to preserve visual function.

GNH USA supplies Monoprost as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements for ophthalmic medicines. The company’s global distribution network ensures reliable delivery and support for eye‑care providers across diverse markets.

Latanoprost is a prostaglandin analog used to manage conditions characterized by elevated intra‑ocular pressure.

Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. Ocular hypertension: lowers pressure to prevent conversion to glaucoma. Secondary open‑angle glaucoma: assists in pressure control when other ocular conditions contribute to elevated pressure.

Latanoprost may cause ocular and systemic reactions.

Common Side Effects: - Eye redness or hyperemia. - Increased eyelash length and thickness. - Darkening of the iris pigment. - Eye irritation or foreign‑body sensation. - Blurred vision. - Mild eye pain.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema, anaphylaxis). - Uveitis or intra‑ocular inflammation. - Corneal edema or keratitis. - Paradoxical increase in intra‑ocular pressure. - Persistent visual disturbances. - Endophthalmitis (rare infection inside the eye).

Before using Monoprost, consider the following precautions.

Monitor IOP: schedule regular intra‑ocular pressure measurements. Assess for ocular infections: avoid use if active eye infection is present. Avoid in active uveitis: contraindicated in inflammatory eye conditions. Check for hypersensitivity: discontinue if allergic signs appear. Pregnancy and lactation: safety not established; use only if benefit outweighs risk. Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Co‑administration with other prostaglandin analog eye drops: increased risk of ocular side effects. - Use with preservative‑containing contact lens solutions: may heighten ocular irritation.

Moderate Interactions (Monitor Closely): - Systemic carbonic anhydrase inhibitors: possible additive IOP‑lowering effect. - Topical corticosteroids: may reduce latanoprost efficacy. - Anticholinergic eye drops: may affect pupil dynamics and IOP control.